Conclusions
Pediatric oncology patients have suboptimal response to COVID-19
vaccination compared to healthy controls. Booster shots should be
encouraged to improve immunity and reduce risk of severe disease.
Further work in larger cohorts of patients is needed to understand how
malignancy type, blood counts, and intensity of therapy may impact
immune response.
Conflict of Interest Statement : The authors have no conflicts
of interest to discolose.
Acknowledgements : none